Non-Alcoholic Fatty Liver Disease (NAFLD) is on the rise globally, affecting an estimated 38% of the population. This disease is closely linked to obesity, diabetes, and sedentary lifestyles, making it an emerging global health concern. NAFLD can progress to severe conditions such as non-alcoholic steatohepatitis (NASH) and liver cancer if left untreated. While no specific drugs are approved for treating NAFLD, lifestyle changes such as weight loss through a healthy diet and exercise are recommended. Controlling comorbid conditions like type 2 diabetes and hypertension is also important. Some treatments, like saroglitazar and vitamin E, have shown positive results in NASH patients. Research is ongoing for new therapies like obeticholic acid. Early diagnosis and proactive measures are crucial in preventing and managing NAFLD. It is important to seek medical advice for any concerns regarding liver health. This article serves as informational and not a substitute for professional medical advice.
Note: The image is for illustrative purposes only and is not the original image associated with the presented article. Due to copyright reasons, we are unable to use the original images. However, you can still enjoy the accurate and up-to-date content and information provided.
